Related references
Note: Only part of the references are listed.Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies
Kian Fan Chung
JOURNAL OF INTERNAL MEDICINE (2016)
Roles of Periostin in Respiratory Disorders
Kenji Izuhara et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
IL-4 and IL-13 signaling in allergic airway disease
Naina Gour et al.
CYTOKINE (2015)
Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Nicola A. Hanania et al.
THORAX (2015)
Tailored therapy for severe asthma
Francesco Menzella et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2015)
Biologic targeted therapy in allergic asthma
Jeffrey B. Bice et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2014)
Future Biologic Therapies in Asthma
Santiago Quirce et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2014)
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge
H. Scheerens et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Adult asthma biomarkers
Mi-Ae Kim et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Periostin, a novel biomarker of TH2-driven asthma
Amit D. Parulekar et al.
CURRENT OPINION IN PULMONARY MEDICINE (2014)
Monoclonal antibodies for the treatment of refractory asthma
Nathan Hambly et al.
CURRENT OPINION IN PULMONARY MEDICINE (2014)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Which Biomarkers Are Effective for Identifying Th2-Driven Inflammation in Asthma?
Zuzana Diamant et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
Role of Interleukin-13 in Asthma
Jonathan Corren
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
Asthma phenotypes and endotypes
Ting-Yu Lin et al.
CURRENT OPINION IN PULMONARY MEDICINE (2013)
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
Michael Noonan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
Mark Ultsch et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
New treatments for severe treatment-resistant asthma: targeting the right patient
Kian Fan Chung
LANCET RESPIRATORY MEDICINE (2013)
Severe asthma: from characteristics to phenotypes to endotypes
S. Wenzel
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
IL-13 in asthma and allergic disease: Asthma phenotypes and targeted therapies
Jennifer L. Ingram et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Asthma phenotypes: the evolution from clinical to molecular approaches
Sally E. Wenzel
NATURE MEDICINE (2012)
Lebrikizumab in the personalized management of asthma
Neil C. Thomson et al.
BIOLOGICS-TARGETS & THERAPY (2012)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
T-helper Type 2-driven Inflammation Defines Major Subphenotypes of Asthma
Prescott G. Woodruff et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Increased sputum and bronchial biopsy IL-13 expression in severe asthma
Shironjit K. Saha et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis
MA Berry et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
M Masoli et al.
ALLERGY (2004)
Share Paper
